Walleye Capital’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-51,400
Closed -$282K 1484
2019
Q4
$282K Buy
51,400
+31,600
+160% +$178K 0.02% 953
2019
Q3
$113K Sell
19,800
-38,100
-66% -$259K 0.01% 1398
2019
Q2
$444K Buy
57,900
+54,800
+1,768% +$295K 0.05% 543
2019
Q1
$16K Buy
+3,100
New +$21.5K ﹤0.01% 1371

Other funds holding PGEN

Walleye Capital's PGEN Position: Q3 2021 in Review

Walleye Capital sold out of Precigen (PGEN) in Q3 2021, closing a stake of 10,496 shares — an estimated $68 sold.

Walleye Capital first reported a position in PGEN in Q1 2019 and held it in 4 quarters. The position peaked at $194K in Q3 2019. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

  • Walleye Capital reported no remaining Precigen position as of Q3 2021 after selling out during the quarter.
  • Walleye Capital sold 10,496 Precigen shares in Q3 2021, an estimated $68.
  • Walleye Capital first reported a position in Precigen in Q1 2019 and held it in 4 quarters.
  • Walleye Capital's Precigen position peaked at $194K in Q3 2019.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on Walleye Capital's 13F filing for Q3 2021, filed 15 Nov 2021.